← Eichor
Study identifier: NCT06778954 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Ropivacaine-Poloxamer 407 Gel for Pain Control After Open Gastrectomy

Condition: Gastric Cancer  ·  Sponsor: Gangnam Severance Hospital

PhaseNA
Planned participants48
Who can joinAll sexes, 20 Years to no upper limit
Healthy volunteersNo

About this study

The study evaluates the efficacy of Ropivacaine-Poloxamer 407 hydrogel in reducing postoperative pain following open gastrectomy.

This description comes directly from the study's public registry record.

Talk to the study team

Shiyeol Jun  ·  82-2-2019-4601  ·  gsirb@yuhs.ac

Always discuss trial participation with your own doctor first.

Locations (1)

GangnamSeverance HospitalSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06778954